Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8239960 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 6 Pages |
Abstract
High-dose-rate-EB may be an effective treatment for select patients with refractory hyperplastic granulation tissue causing recurrent airway stenosis. Performing HDR-EB within 24-48 h after excision of obstructive granulation tissue could further improve outcomes. Careful patient selection is important to maximize therapeutic benefit and minimize toxicity. The optimal patient population, dose, and timing of HDR-EB should be investigated prospectively.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Rahul D. M.D., Peter A. M.D., Chandana A. M.S., Thomas R. M.D., Michael M.D., Atul C. M.D.,